BJTRF (Beijing Tong Ren Tang Chinese Medicine Co) WACC %:6.58% (As of Jul. 19, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJTRF Beijing Tong Ren Tang Chinese Medicine Co Ltd BJTRF
89 GF Score
Price $0.65
GF Value $0.91
! 3 Warning Signs
View Full Analysis

What is Beijing Tong Ren Tang Chinese Medicine Co WACC %?

Beijing Tong Ren Tang Chinese Medicine Co BJTRF 89 WACC % is 6.58% as of Jul. 19, 2026, which is 9% below its 10-year median of 7.20. GuruFocus rates BJTRF with a GF Score™ of 89/100 and a GF Value™ of $0.91. The stock has 3 warning signs investors should review. Among 1,021 Drug Manufacturers companies, Beijing Tong Ren Tang Chinese Medicine Co ranks better than 60.04% on this metric.

As of today (2026-07-19), Beijing Tong Ren Tang Chinese Medicine Co's weighted average cost of capital is 6.58%%. Beijing Tong Ren Tang Chinese Medicine Co's ROIC % is 17.89% (calculated using TTM income statement data). Beijing Tong Ren Tang Chinese Medicine Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

For a comprehensive WACC calculation, please access the WACC Calculator.


Beijing Tong Ren Tang Chinese Medicine Co  (OTCPK:BJTRF) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Beijing Tong Ren Tang Chinese Medicine Co's weighted average cost of capital is 6.58%%. Beijing Tong Ren Tang Chinese Medicine Co's ROIC % is 17.89% (calculated using TTM income statement data). Beijing Tong Ren Tang Chinese Medicine Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year semi-annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year semi-annual average debt to get the simplified cost of debt.


Related Terms

Beijing Tong Ren Tang Chinese Medicine Co WACC % Historical Data

* Premium members only.

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tong Ren Tang Chinese Medicine Co WACC % Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
WACC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.65 8.42 7.58 8.09 6.82

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
WACC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.58 7.95 8.09 7.37 6.82

BJTRF vs ZTS, UTHR: WACC % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tong Ren Tang Chinese Medicine Co's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tong Ren Tang Chinese Medicine Co WACC % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Tong Ren Tang Chinese Medicine Co's WACC % distribution charts can be found below:

* The bar in red indicates where Beijing Tong Ren Tang Chinese Medicine Co's WACC % falls into.


BJTRF
89GF Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd BJTRF
WACC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tong Ren Tang Chinese Medicine Co WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Beijing Tong Ren Tang Chinese Medicine Co's market capitalization (E) is $736.611 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year semi-annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Dec. 2025, Beijing Tong Ren Tang Chinese Medicine Co's latest one-year semi-annual average Book Value of Debt (D) is $16.7743 Mil.
a) weight of equity = E / (E + D) = 736.611 / (736.611 + 16.7743) = 0.9777
b) weight of debt = D / (E + D) = 16.7743 / (736.611 + 16.7743) = 0.0223

2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.551%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Beijing Tong Ren Tang Chinese Medicine Co's beta is 0.3488.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.551% + 0.3488 * 6% = 6.6438%

3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year semi-annual average debt to get the simplified cost of debt.
As of Dec. 2025, Beijing Tong Ren Tang Chinese Medicine Co's interest expense (positive number) was $0.724 Mil. Its total Book Value of Debt (D) is $16.7743 Mil.
Cost of Debt = 0.724 / 16.7743 = 4.3161%.

4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = 11.239 / 64.541 = 17.41%.

Beijing Tong Ren Tang Chinese Medicine Co's Weighted Average Cost Of Capital (WACC) for Today is calculated as:

WACC=E / (E + D)*Cost of Equity+D / (E + D)*Cost of Debt*(1 - Tax Rate)
=0.9777*6.6438%+0.0223*4.3161%*(1 - 17.41%)
=6.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 6.58% mean?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a WACC % of 6.58% as of Jul. 19, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. This is near median its historical median of 7.20. Over the past decade, Beijing Tong Ren Tang Chinese Medicine Co's WACC % has ranged from 4.52 to 8.86. According to the industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #408 out of 1021 companies in the Drug Manufacturers industry, placing it in the top 40%.
Is Beijing Tong Ren Tang Chinese Medicine Co's WACC % too high?
Beijing Tong Ren Tang Chinese Medicine Co's current WACC % of 6.58% is near median its 10-year median of 7.20. Over the past 10 years, this metric has ranged from a low of 4.52 to a high of 8.86. The Drug Manufacturers industry median WACC % is 8.99. Beijing Tong Ren Tang Chinese Medicine Co's value of 6.58% is 26.8% below this industry median. Based on the distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #408 out of 1021 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's WACC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #408 out of 1021 companies for WACC %. This puts Beijing Tong Ren Tang Chinese Medicine Co in the upper half of its industry. The industry median WACC % is 8.99. Beijing Tong Ren Tang Chinese Medicine Co's value of 6.58% is 26.8% below this benchmark. Historically, Beijing Tong Ren Tang Chinese Medicine Co's own WACC % has ranged from 4.52 to 8.86 over the past decade. While the company's 10-year median is 7.20 vs. the industry median of 8.99, Beijing Tong Ren Tang Chinese Medicine Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Drug Manufacturers company?
The median WACC % among Drug Manufacturers companies is 8.99, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tong Ren Tang Chinese Medicine Co's current WACC % of 6.58% is 26.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. For the Drug Manufacturers industry, the median WACC % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tong Ren Tang Chinese Medicine Co's current WACC % is 6.58%, which is near median its own 10-year median of 7.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a current WACC % of 6.58%. The stock's GF Value™ is $0.91, compared to a current price of $0.65 — trading 28.7% below its estimated fair value. The current WACC % is 6.58%, which is near median its 10-year median of 7.20 and 26.8% below the Drug Manufacturers industry median of 8.99. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (BJTRF), the current WACC % is 6.58% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued. The current stock price of $0.65 is trading 28.7% below its estimated GF Value™ of $0.91.

Key valuation signals for BJTRF:

  • WACC %: 6.58% (near median its 10-year median of 7.20)
  • GF Value™: $0.91 vs. price of $0.65 (28.7% below fair value)
  • GF Score™: 89/100 with 3 warning signs
  • Industry Position: 26.8% below the Drug Manufacturers median (#408 of 1021)

No single metric tells the full story. See the BJTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Tong Ren Tang Chinese Medicine Co Business Description

Other Exchanges 03613:Hong KongTQR:Germany
Address Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
89GF Score

Get the complete analysis for BJTRF

WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$0.91
GF Value